A Prospective, Multicenter, Randomized Control Study To Determine Clinical Effectiveness, Patient Wellness and Cost of Pain Related Care of In-Elastic Lumbar Sacral Orthoses Versus Standard Medical Treatment in Patients Presenting With Acute Low Back Pain In Primary Care Centers (The ARREST Study)
- Conditions
- Back PainLow Back Pain
- Interventions
- Device: Aspen Horizon 627 LSO
- Registration Number
- NCT03100097
- Lead Sponsor
- Aspen Medical Products
- Brief Summary
The objective of this study is to evaluate sixty male and non-pregnant female patients diagnosed with acute moderate to severe low back pain with the onset of symptoms within 30 days. To evaluate functional improvement following a 4-week use of an in-elastic lumbar sacral orthosis (LSO) as a treatment modality for acute low back pain.
- Detailed Description
The objective of this study is to evaluate sixty male and non-pregnant female patients diagnosed with acute moderate to severe low back pain with the onset of symptoms within 30 days. To evaluate functional improvement following a 4-week use of an in-elastic lumbar sacral orthosis (LSO) as a treatment modality for acute low back pain.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 62
o Moderate to complete disability (baseline ODI score of 21 to 80 percent) *
- Pregnant patients
- Patients considering pregnancy
- Patients in any other investigational device or drug study
- Patients unwilling to return for follow up
- Patients unwilling to provide access to medical claims associated with pain management.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention (Aspen Horizon 627 LSO) Aspen Horizon 627 LSO Patients receive a lumbar brace, Aspen Horizon 627 LSO, in addition to normal medical management
- Primary Outcome Measures
Name Time Method 40% change in Oswestry Disability Index 4 weeks Oswestry Disability Index
- Secondary Outcome Measures
Name Time Method Change in Opioid utilization 4 weeks, 8 weeks, 12 weeks Change in Opioid utilization
General Health Survey 12 weeks SF36v2 Health Survey
Number of participants with treatment-related adverse events as assessed by questionnaire 4 weeks, 8 weeks, 12 weeks Were any complications associated wearing of the brace noted in patients questionnaires